---
title: "GLAXO GROUP LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8
json: https://whiteintel.dev/api/public/dossier/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8
identifier: oo:GB-COH-00305979
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GLAXO GROUP LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-00305979`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8  

## Cross-source identity

The same real-world entity, resolved across sources:

- **Glaxo Group Limited** — source · `gb-coh:305979` — https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340
- **GLAXO GROUP LIMITED** — GLEIF · `lei:5493006TSD23CIX01B10` — https://whiteintel.dev/entity/df0c7b66-a947-5fe3-b563-359460036544

## Ownership & control

### Owners / controllers

- **GLAXOSMITHKLINE FINANCE PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850
- **Glaxosmithkline Finance Plc** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c4260dcc-2978-4402-9aeb-307778f2117e

### Holdings / subsidiaries

- **GLAXOSMITHKLINE EXPORT LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/893203cd-f7d8-5931-92e2-c77f6b4671e5
- **TRES CANTOS OPEN LAB FOUNDATION** (beneficial owner) — 100% — https://whiteintel.dev/entity/25b45ebe-f081-5a34-bb8e-e6ae9bfcac92
- **GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.5) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/ecf7cd25-7e8c-57c0-be47-ad12cbbf7834
- **GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9a18cd20-00b5-5c15-9e43-d29cafb31e52
- **MONTROSE FINE CHEMICAL COMPANY LTD.** (beneficial owner) — 100% — https://whiteintel.dev/entity/0aeb1cf6-554d-5033-b696-e5a5b7343823
- **DOMANTIS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/244798d7-2005-5445-984c-83a3c47b3d78
- **GLAXOSMITHKLINE US TRADING LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/dea88797-d6fb-50ff-9a3f-e1593b1d6286
- **GLAXO OPERATIONS UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f65ae004-5704-5af9-8e89-f34ac2cc722b
- **CLARGES PHARMACEUTICALS TRUSTEES LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/76f8a092-39e8-58ef-9d94-49c11bc1fc16
- **GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/12c0625c-4ae2-59d5-8371-1c70aae07677
- **GLAXOSMITHKLINE UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/a093deef-8da6-5842-b50e-84acf1d410b8
- **GLAXO WELLCOME UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/0094c661-0ce9-5b24-8f2f-c0ccaae6c4f1

…and **11** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

### UBO chain (walk to the ultimate owner)

A **12-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `00305979`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 1935-10-14
- **Registered office:** Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
- **SIC:** 70100

### Officers

- WHYTE, Victoria Anne — secretary · British · appointed 2001-06-06
- WALKER, Adam — director · British · appointed 2015-10-01
- EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED — corporate director · appointed 2001-01-31
- THE WELLCOME FOUNDATION LIMITED — corporate director · appointed 2002-03-05
- BICKNELL, Simon Michael — secretary · British · appointed 2001-01-31 · resigned 2011-02-28
- COWDEN, Stephen John — secretary · British · appointed 1996-02-01 · resigned 2001-01-31
- HYDE, Jonathan Laurence Patrick — secretary · British · resigned 1993-01-31
- MORRIS, Nicholas Guy Usher — secretary · British · appointed 1993-02-01 · resigned 1996-02-01
- STEPHENS, Richard James — secretary · British · appointed 2003-07-21 · resigned 2007-03-05
- ADAM, Christopher — director · British · resigned 1993-01-31
- ANDO, Goran Albert Torstensson, Doctor — director · Swedish · resigned 1993-01-31
- BLACKBURN, Paul Frederick — director · British · appointed 2005-07-21 · resigned 2016-03-01
- BLAKER, Graham Joseph, Dr — director · British · resigned 1993-01-31
- BROWN, Julie Belita — director · British · appointed 2023-05-01 · resigned 2025-07-19
- CHALLONER, Stanley Clive — director · British · resigned 1993-01-31
- COCHRANE, James Michael Thomas — director · British · appointed 1995-09-06 · resigned 2001-01-31
- COOMBE, John David — director · British · resigned 2005-03-31
- DINGEMANS, Simon Paul — director · British · appointed 2011-04-01 · resigned 2019-05-01
- EAVES, Terence, Doctor — director · British · resigned 1993-01-31
- GIROLAMI, Paul, Sir — director · British · appointed 1993-05-12 · resigned 1994-10-11

### Beneficial owners (Persons with Significant Control)

- [Glaxosmithkline Finance Plc](https://whiteintel.dev/entity/c4260dcc-2978-4402-9aeb-307778f2117e) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/00305979
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/00305979

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GLAXO GROUP LIMITED** — https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GLAXO GROUP LIMITED**. Human view: https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8 · Structured JSON: https://whiteintel.dev/api/public/dossier/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._